All Stories

  1. Analysis of genes to predict the effects of proprotein convertase subtilisin/kexin type 9-inhibitors and statins
  2. Simplified algorithm to facilitate communication of familial hypercholesterolaemia: Figure 1
  3. Heart rate on admission independently predicts in-hospital mortality in acute ischemic stroke patients
  4. Risk prediction with proprotein convertase subtilisin/kexin type 9 (PCSK9) in patients with stable coronary disease on statin treatment
  5. Risk prediction with triglycerides in patients with stable coronary disease on statin treatment
  6. Understanding IMPROVE-IT and the cardinal role of LDL-C lowering in CVD prevention
  7. Improvements in Left Ventricular Hypertrophy and Diastolic Function Following Renal Denervation
  8. The relationships of phytosterols and oxyphytosterols in plasma and aortic valve cusps in patients with severe aortic stenosis
  9. Rac1-Mediated Effects of HMG-CoA Reductase Inhibitors (Statins) in Cardiovascular Disease
  10. New AHA and ACC guidelines on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk
  11. Systems Genetics of Liver Fibrosis: Identification of Fibrogenic and Expression Quantitative Trait Loci in the BXD Murine Reference Population
  12. Hemmung der Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9)
  13. Renal Denervation in Moderate Treatment-Resistant Hypertension
  14. Orthostatic function after renal sympathetic denervation in patients with resistant hypertension
  15. Association of vitamin D status and blood pressure response after renal denervation
  16. Targeting the Proprotein Convertase Subtilisin/Kexin Type 9 for the Treatment of Dyslipidemia and Atherosclerosis
  17. Drug adherence in patients taking oral anticoagulation therapy
  18. Heart rate: A global target for cardiovascular disease and therapy along the cardiovascular disease continuum
  19. Effects of renal sympathetic denervation on heart rate and atrioventricular conduction in patients with resistant hypertension
  20. Effects of nonpersistence with medication on outcomes in high-risk patients with cardiovascular disease
  21. Renal Denervation in the Treatment of Hypertension
  22. Junge Frau mit isolierter Lipoprotein(a)-Erhöhung
  23. Diesel Exhaust Particles Impair Endothelial Progenitor Cells, Compromise Endothelial Integrity, Reduce Neoangiogenesis, and Increase Atherogenesis in Mice
  24. HOW EFFECTIVE IS RENAL DENERVATION IN LESS SEVERE TREATMENT RESISTANT HYPERTENSION?
  25. Effects of omega-3 fatty acids on postprandial triglycerides and monocyte activation
  26. TCT-211 Ambulatory blood pressure and dipping-pattern after catheter-based renal sympathetic denervation in patients with resistant hypertension
  27. TCT-13 Renal resistive indices, urinary albumin excretion and renal function in patients with resistant hypertension after catheter-based renal sympathetic denervation
  28. TCT-14 Effects of renal sympathetic denervation on heart rate and atrioventricular conduction in patients with resistant hypertension
  29. Role of miR-21 in the pathogenesis of atrial fibrosis
  30. Letter by Weingärtner et al Regarding Article, “Combined Effects of Ezetimibe and Phytosterols on Cholesterol Metabolism: A Randomized, Controlled Feeding Study in Humans”
  31. Acute Effects of Statins
  32. Heart Rate Reduction by Ivabradine Improves Aortic Compliance in Apolipoprotein E-Deficient Mice
  33. Validation of an isotope dilution gas chromatography–mass spectrometry method for analysis of 7-oxygenated campesterol and sitosterol in human serum
  34. Markers of enhanced cholesterol absorption are a strong predictor for cardiovascular diseases in patients without diabetes mellitus
  35. Troponin elevation in acute ischemic stroke (TRELAS) - protocol of a prospective observational trial
  36. 655 PLANT STEROL AND STANOL ESTERS INDUCE DIFFERENTIAL EFFECTS ON OXIDATIVE STRESS, INFLAMMATION, LEUCOCYTES, VASCULAR FUNCTION AND TISSUE CONCENTRATIONS IN MICE
  37. Paclitaxel and sirolimus differentially affect growth and motility of endothelial progenitor cells and coronary artery smooth muscle cells
  38. Reply
  39. Pioglitazone activates aortic telomerase and prevents stress-induced endothelial apoptosis
  40. Increased lysyl oxidase expression and collagen cross-linking during atrial fibrillation
  41. Cardiovascular Disease and Dyslipidemia: Beyond LDL
  42. Differential effects on inhibition of cholesterol absorption by plant stanol and plant sterol esters in apoE-/- mice
  43. Late-breaking clinical trials presented at the American Heart Association Congress in Chicago 2010
  44. Vascular Pathophysiology in Response to Increased Heart Rate
  45. Nutrition, environment and cardiovascular health (NESCAV): protocol of an inter-regional cross-sectional study
  46. The Relationships of Markers of Cholesterol Homeostasis with Carotid Intima-Media Thickness
  47. The renin inhibitor aliskiren upregulates pro-angiogenic cells and reduces atherogenesis in mice
  48. Angiotensin-receptor blockade, cancer, and concerns
  49. Heart rate reduction with ivabradine improves erectile dysfunction in parallel to decrease in atherosclerotic plaque load in ApoE-knockout mice
  50. Heart rate reduction in cardiovascular disease and therapy
  51. Cardiological evaluation after cerebral ischaemia
  52. Relationship between cholesterol synthesis and intestinal absorption is associated with cardiovascular risk
  53. Integrin-linked kinase is a central mediator in angiotensin II type 1- and chemokine receptor CXCR4 signaling in myocardial hypertrophy
  54. P127 MARKERS OF CHOLESTEROL METABOLISM ARE ASSOCIATED WITH CAROTID INTIMA-MEDIA THICKNESS
  55. HDL und Arteriosklerose – Korrelation mit dem Auftreten kardiovaskulärer Ereignisse
  56. An alternative pathway of reverse cholesterol transport: The oxysterol 27-hydroxycholesterol
  57. Rac1-Induced Connective Tissue Growth Factor Regulates Connexin 43 and N-Cadherin Expression in Atrial Fibrillation
  58. Antioxidative Properties of Statins in the Heart
  59. Alterations in cholesterol homeostasis are associated with coronary heart disease in patients with aortic stenosis
  60. Inhibitory effect of estrogen on Rac1-expression in monocytes
  61. Brauchen alle Patienten mit KHK bzw. Diabetes ein Statin?
  62. Epidemiologie und Prävention
  63. Highlights of the hotline sessions presented at the scientific sessions 2008 of the American Heart Association
  64. Atrial fibrillation in heart failure: Current treatment of patients with remodeled atria
  65. Prevention of Atrial Fibrillation With 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors
  66. Antioxidative effects of statins
  67. Effects of Physical Exercise on Myocardial Telomere-Regulating Proteins, Survival Pathways, and Apoptosis
  68. Endothelial Nitric Oxide Synthase – A Target for Stroke Protection by Statins
  69. Heart Rate Reduction by Ivabradine Reduces Oxidative Stress, Improves Endothelial Function, and Prevents Atherosclerosis in Apolipoprotein E–Deficient Mice
  70. Vascular Effects of Diet Supplementation With Plant Sterols
  71. The Medical Case for the Development of an Intravenous Statin Formulation – Beyond Ischemic Stroke
  72. Clinical Trial Updates and Hotline Sessions presented at the Scientific Session 2007 of the American heart association
  73. Aktuelle Kardiologie 2006/2007
  74. Role of Rac1 GTPase Activation in Atrial Fibrillation
  75. The PPAR-γ agonist pioglitazone increases neoangiogenesis and prevents apoptosis of endothelial progenitor cells
  76. Perceived psychosocial stress and cardiovascular risk factors in obese and non-obese patients
  77. Physical Exercise and Endothelial Progenitor Cells
  78. Regulation of endothelial progenitor cells by prostaglandin E1 via inhibition of apoptosis
  79. Metabolic Syndrome and Heart Failure
  80. HMG-CoA Reductase Inhibitors in Chronic Heart Failure
  81. Physical activity promotes angio- and vasculogenesis in the post-ischemic brain
  82. Running exercise of different duration and intensity: effect on endothelial progenitor cells in healthy subjects
  83. Long-term effects of chronic statin treatment in the post-ischemic brain
  84. PLEIOTROPIC EFFECTS OF STATINS
  85. Targeting eNOS for stroke protection
  86. Physical Training Increases Endothelial Progenitor Cells, Inhibits Neointima Formation, and Enhances Angiogenesis
  87. Effect of atorvastatin 80 mg on endothelial cell function (forearm blood flow) in patients with pretreatment serum low-density lipoprotein cholesterol levels <130 mg/dl
  88. Mechanisms of stroke protection by physical activity
  89. Isoprenoid metabolism and the pleiotropic effects of statins
  90. Significance of cholesterol-independent effects of statins
  91. Rosuvastatin, a new HMG-CoA reductase inhibitor, upregulates endothelial nitric oxide synthase and protects from ischemic stroke in mice
  92. Pleiotropic effects of HMG-CoA reductase inhibitors
  93. Rapid effects on vascular function after initiation and withdrawal of atorvastatin in healthy, normocholesterolemic men
  94. Targeting Rho in Cardiovascular Disease
  95. Neuroprotection mediated by changes in the endothelial actin cytoskeleton
  96. Endothelial Nitric Oxide Synthase-Dependent Cerebral Blood Flow Augmentation by L-Arginine After Chronic Statin Treatment
  97. Regulation der endothelialen NO-Produktion durch Rho-GTPasen
  98. Effects of endotoxin on human myocardial contractility involvement of nitric oxide and peroxynitrite
  99. Upregulation of Endothelial Nitric Oxide Synthase by HMG CoA Reductase Inhibitors
  100. Chronic Eosinophilic Pneumonia with Atypical Radiographic Presentation
  101. European Heart Journal - My Cardio Interview: Ulrich Laufs, Philip Barter & Ulf Landmesser on Post-prandial
  102. Nuclear Run-On Assay to Study Gene Transcription in Vascular Cells